Back to top
more

Omnicell (OMCL)

(Delayed Data from NSDQ)

$33.08 USD

33.08
485,283

-0.33 (-0.99%)

Updated Aug 28, 2026 04:00 PM ET

After-Market: $33.11 +0.03 (0.09%) 4:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 248)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus

by Zacks Equity Research

CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and streamline reviews.

Zacks Equity Research

KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic

by Zacks Equity Research

KORU Medical filed a 510(k) to use FreedomEDGE for subcutaneous PHESGO delivery, expanding into oncology and simplifying breast cancer care.

Zacks Equity Research

Implied Volatility Surging for Omnicell Stock Options

by Zacks Equity Research

Investors need to pay close attention to Omnicell stock based on the movements in the options market lately.

Zacks Equity Research

FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform

by Zacks Equity Research

Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

Zacks Equity Research

How the OneStep Partnership Could Drive Growth for ZBH Stock

by Zacks Equity Research

Zimmer Biomet teams up with OneStep to integrate mobility analytics into mymobility, empowering surgeons and patients while advancing its connected care strategy.

Zacks Equity Research

Best Momentum Stocks to Buy for Dec. 16

by Zacks Equity Research

PAAS, OMCL and MDB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Dec. 16, 2025.

Zacks Equity Research

New Strong Buy Stocks for Dec. 16: MDB, OMCL, and More

by Zacks Equity Research

COF, QCRH, TNET, MDB and OMCL have been added to the Zacks Rank #1 (Strong Buy) List on Dec. 16, 2025.

Zacks Equity Research

CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents

by Zacks Equity Research

CVS Health shares jump after the company begins offering MMR vaccines across South Carolina pharmacies and clinics post a measles outbreak.

Zacks Equity Research

Is it Worth Retaining NEOG Stock in Your Portfolio for Now?

by Zacks Equity Research

Neogen leans on new product launches and 3M Food Safety integration to offset solvency strains and macro pressures.

Zacks Equity Research

Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It?

by Zacks Equity Research

PAHC's 59% YTD surge rides on strong Animal Health momentum, booming vaccines and global gains despite the rising competition.